Patents/Inventors

Manmohan Reddy Leleti

Dublin, CAUS21 patents

23 Patents

US124599672025
Modulators of 5′-nucleotidase, Ecto and the Use Thereof
Arcus Biosciences, Inc.
0 cites
US124338362025
Parenterally Administered Immune Enhancing Drugs
ARCUS BIOSCIENCES, Inc.
0 cites
US124101702025
2,3,5-trisubstituted Pyrazolo[1,5-a]pyrimidine Compounds
Arcus Biosciences, Inc.
0 cites
US123847732025
Thiazole Compounds and Methods of Use Thereof
Arcus Biosciences, Inc.
0 cites
US122264252025
Inhibitors of ARG1 And/or ARG2
Arcus Biosciences, Inc.
0 cites
US121954472025
Azolopyrimidine for the Treatment of Cancer-related Disorders
ARCUS BIOSCIENCES, Inc.
0 cites
US121954822025
Compounds as Inhibitors of AXL
Arcus Biosciences, Inc.
0 cites
US121680232024
Inhibitors of Adenosine 5′-nucleotidase
Arcus Biosciences, Inc.
0 cites
US121459012024
Process for Preparing Tetralin Compounds
Arcus Biosciences, Inc.
0 cites
US121394752024
2-oxindole Compounds
CHEMOCENTRYX, Inc.
0 cites
US121039072024
Tetralin and Tetrahydroquinoline Compounds as Inhibitors of Hif-2alpha
Arcus Biosciences, Inc.
0 cites
US120714112024
Inhibitors of Hif-2α and Methods of Use Thereof
Arcus Biosciences, Inc.
0 cites
US120644332024
Pyridone A2R Antagonists
ARCUS BIOSCIENCES, Inc.
0 cites
US119935842024
Solid Forms of an Azolopyrimidine Compound
ARCUS BIOSCIENCES, Inc.
0 cites
US119512142024
Capsule Formulations
CHEMOCENTRYX, Inc.
0 cites
US119458052024
Inhibitors of CXCR2
CHEMOCENTRYX, Inc
0 cites
US119313432024
CD73 Inhibitors
Arcus Biosciences, Inc.
0 cites
US118846542024
Substituted Anilines as CCR(4) Antagonists
CHEMOCENTRYX, Inc.
0 cites
US118207592023
Modulators of Chemokine Receptors
CHEMOCENTRYX, Inc.
0 cites
US117877622023
Tetralin and Tetrahydroquinoline Compounds as Inhibitors of Hif-2alpha
ARCUS BIOSCIENCES, Inc.
0 cites
US116676622023
Modulators of 5′-nucleotidase, Ecto and the Use Thereof
ARCUS BIOSCIENCES, Inc.
0 cites
US116334162023
Oral Formulations of CD73 Compounds
ARCUS BIOSCIENCES, Inc.
0 cites
US116033562023
Amorphous Form of a Complement Component C5a Receptor
CHEMOCENTRYX, Inc.
0 cites